A Good Prognosis At Sun HealthcareBy
Sun Healthcare Group is engaged in a David-and-Goliath merger with the much-larger Mediplex Group. But the deal hasn't attracted much attention. That's just dandy for some investors, who see the buyout making Sun a major player in the nursing-home, advanced-care, and pharmaceutical-service businesses. The stock is down to 19--following a runup to 25 in March and April after the deal was announced.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.